ROVI signs a letter of intentions for the production of vaccines for seasonal and pandemic influenza
30-Mar-2010 -
Laboratorios Farmacéuticos Rovi (ROVI) announced that the company has signed a letter of intentions with Novartis Vaccines, with the aim of exploring a definitive agreement for the transfer of the patented technology of Novartis Vaccines needed for the production of vaccines against seasonal and ...
cell cultures
joint ventures
Novartis
+4